Healthcare -
Biotechnology - NASDAQ - US
$ 8.1
0.621 %
$ 553 M
Market Cap
-4.07
P/E
EYPT - TOTAL CURRENT LIABILITIES
Total Current Liabilities EYPT - EyePoint Pharmaceuticals, Inc.
63.3 M
LAST VALUE
63.53%
2 YEAR CAGR
23.90%
5 YEAR CAGR
34.35%
10 YEAR CAGR